Cargando…
Realising the therapeutic potential of neuroactive steroid modulators of the GABA(A) receptor
In the 1980s particular endogenous metabolites of progesterone and of deoxycorticosterone were revealed to be potent, efficacious, positive allosteric modulators (PAMs) of the GABA(A) receptor (GABA(A)R). These reports were followed by the discovery that such steroids may be synthesised not only in...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231973/ https://www.ncbi.nlm.nih.gov/pubmed/32435660 http://dx.doi.org/10.1016/j.ynstr.2019.100207 |
_version_ | 1783535285318975488 |
---|---|
author | Belelli, Delia Hogenkamp, Derk Gee, Kelvin W. Lambert, Jeremy J. |
author_facet | Belelli, Delia Hogenkamp, Derk Gee, Kelvin W. Lambert, Jeremy J. |
author_sort | Belelli, Delia |
collection | PubMed |
description | In the 1980s particular endogenous metabolites of progesterone and of deoxycorticosterone were revealed to be potent, efficacious, positive allosteric modulators (PAMs) of the GABA(A) receptor (GABA(A)R). These reports were followed by the discovery that such steroids may be synthesised not only in peripheral endocrine glands, but locally in the central nervous system (CNS), to potentially act as paracrine, or autocrine “neurosteroid” messengers, thereby fine tuning neuronal inhibition. These discoveries triggered enthusiasm to elucidate the physiological role of such neurosteroids and explore whether their levels may be perturbed in particular psychiatric and neurological disorders. In preclinical studies the GABA(A)R-active steroids were shown to exhibit anxiolytic, anticonvulsant, analgesic and sedative properties and at relatively high doses to induce a state of general anaesthesia. Collectively, these findings encouraged efforts to investigate the therapeutic potential of neurosteroids and related synthetic analogues. However, following over 30 years of investigation, realising their possible medical potential has proved challenging. The recent FDA approval for the natural neurosteroid allopregnanolone (brexanolone) to treat postpartum depression (PPD) should trigger renewed enthusiasm for neurosteroid research. Here we focus on the influence of neuroactive steroids on GABA-ergic signalling and on the challenges faced in developing such steroids as anaesthetics, sedatives, analgesics, anticonvulsants, antidepressants and as treatments for neurodegenerative disorders. |
format | Online Article Text |
id | pubmed-7231973 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-72319732020-05-20 Realising the therapeutic potential of neuroactive steroid modulators of the GABA(A) receptor Belelli, Delia Hogenkamp, Derk Gee, Kelvin W. Lambert, Jeremy J. Neurobiol Stress Articles from the Special Issue on Allopregnanolone role in the neurobiology of stress and mood disorders; Edited by Graziano Pinna In the 1980s particular endogenous metabolites of progesterone and of deoxycorticosterone were revealed to be potent, efficacious, positive allosteric modulators (PAMs) of the GABA(A) receptor (GABA(A)R). These reports were followed by the discovery that such steroids may be synthesised not only in peripheral endocrine glands, but locally in the central nervous system (CNS), to potentially act as paracrine, or autocrine “neurosteroid” messengers, thereby fine tuning neuronal inhibition. These discoveries triggered enthusiasm to elucidate the physiological role of such neurosteroids and explore whether their levels may be perturbed in particular psychiatric and neurological disorders. In preclinical studies the GABA(A)R-active steroids were shown to exhibit anxiolytic, anticonvulsant, analgesic and sedative properties and at relatively high doses to induce a state of general anaesthesia. Collectively, these findings encouraged efforts to investigate the therapeutic potential of neurosteroids and related synthetic analogues. However, following over 30 years of investigation, realising their possible medical potential has proved challenging. The recent FDA approval for the natural neurosteroid allopregnanolone (brexanolone) to treat postpartum depression (PPD) should trigger renewed enthusiasm for neurosteroid research. Here we focus on the influence of neuroactive steroids on GABA-ergic signalling and on the challenges faced in developing such steroids as anaesthetics, sedatives, analgesics, anticonvulsants, antidepressants and as treatments for neurodegenerative disorders. Elsevier 2019-12-23 /pmc/articles/PMC7231973/ /pubmed/32435660 http://dx.doi.org/10.1016/j.ynstr.2019.100207 Text en © 2019 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Articles from the Special Issue on Allopregnanolone role in the neurobiology of stress and mood disorders; Edited by Graziano Pinna Belelli, Delia Hogenkamp, Derk Gee, Kelvin W. Lambert, Jeremy J. Realising the therapeutic potential of neuroactive steroid modulators of the GABA(A) receptor |
title | Realising the therapeutic potential of neuroactive steroid modulators of the GABA(A) receptor |
title_full | Realising the therapeutic potential of neuroactive steroid modulators of the GABA(A) receptor |
title_fullStr | Realising the therapeutic potential of neuroactive steroid modulators of the GABA(A) receptor |
title_full_unstemmed | Realising the therapeutic potential of neuroactive steroid modulators of the GABA(A) receptor |
title_short | Realising the therapeutic potential of neuroactive steroid modulators of the GABA(A) receptor |
title_sort | realising the therapeutic potential of neuroactive steroid modulators of the gaba(a) receptor |
topic | Articles from the Special Issue on Allopregnanolone role in the neurobiology of stress and mood disorders; Edited by Graziano Pinna |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231973/ https://www.ncbi.nlm.nih.gov/pubmed/32435660 http://dx.doi.org/10.1016/j.ynstr.2019.100207 |
work_keys_str_mv | AT belellidelia realisingthetherapeuticpotentialofneuroactivesteroidmodulatorsofthegabaareceptor AT hogenkampderk realisingthetherapeuticpotentialofneuroactivesteroidmodulatorsofthegabaareceptor AT geekelvinw realisingthetherapeuticpotentialofneuroactivesteroidmodulatorsofthegabaareceptor AT lambertjeremyj realisingthetherapeuticpotentialofneuroactivesteroidmodulatorsofthegabaareceptor |